3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
2
Withdrawn
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other
2
Conditions
Multiple Myeloma
64
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Neoplasms, Plasma Cell
14
Recurrence
12
Leukemia
12
Vomiting
11
Lymphoma, Extranodal NK-T-Cell
11
Lymphoma
11
Neoplasms
9
Nausea
6
Lymphoma, Mantle-Cell
6
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Non-Hodgkin
4
Lymphoma, Follicular
4
Paraproteinemias
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphohistiocytosis, Hemophagocytic
3
Lung Neoplasms
3
Immunoglobulin Light-chain Amyloidosis
3
Hematologic Diseases
3
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Burkitt Lymphoma
3
Breast Neoplasms
3
Blood Protein Disorders
3
Renal Insufficiency
2
Postoperative Nausea and Vomiting
2
Polycystic Ovary Syndrome
2
Peripheral Nervous System Diseases
2
Interventions
Metformin
5
Exercise
3
Diet, Mediterranean
3
Tamoxifen
2
Surveys and Questionnaires
2
Mammography
2
Dexamethasone
2
Counseling
2
semaglutide
1
lime
1
exemestane
1
Utrogestan
1
Topiramate
1
Therapeutics
1
Testosterone
1
Taxes
1
Spironolactone
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Preoperative Exercise
1
Pancreaticoduodenectomy
1
Paclitaxel
1
Ovidrel
1
Nutritional Support
1
Methods
1
Magnetic Resonance Spectroscopy
1
Liraglutide
1
Letrozole
1
Intravital Microscopy
1
Immunoenzyme Techniques
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Obesity
×
Dexamethasone
×
Clear all
NCT01421797
2023-10-27
JCM022
University of Virginia
Phase NA
Unknown
84 enrolled
NCT01421810
2023-10-27
CBS001
University of Virginia
Phase NA
Unknown
80 enrolled